There’s a fascinating anecdote in Peter Spotts’ Christian Science Monitor piece on athletes and doping. After publishing results of tests on a new compound that showed promise in growing extraordinary muscles in mice, University of Pennsylvania researchers were inundated with requests for information, but not from people in the medical community:

After the university published its results, Dr. Wadler says, it was inundated with requests from coaches interested in using it on their athletes.

As a result of the publicity, Wadler says, “more people know about IGF-1 and doping than know about its therapeutic potential” for the elderly or people diagnosed with diseases such as muscular dystrophy.